Physician profile
Manika Agarwal
NPI 1053824987
$95,506.99
in general payments reported to CMS, 2019-2025
3 companies · $4,213 in 2025
The $4,213 reported for 2025 was more than what 98% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
See the full distribution for Orthodontics and Dentofacial Orthopedics
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.57 · 2020: $207 · 2021: $4,278 · 2022: $18K · 2023: $42K · 2024: $26K · 2025: $4,213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $53K · Travel and Lodging: $15K · Food and Beverage: $2,689 · Consulting Fee: $2,629 · Education: $43.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $52,785.85 |
| Travel and Lodging | $14,518.20 |
| Food and Beverage | $2,688.52 |
| Consulting Fee | $2,629.45 |
| Education | $43.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ormco Corporation | $64,487.42 | 2019-2023 | Spark, Damon |
| Envista Holdings Corporation | $30,419.22 | 2024-2025 | Spark, Damon |
| Nobel Biocare USA | $600.35 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manika Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.